Research Article
Alterations in Gene Expression of Renin-Angiotensin System Components and Related Proteins in Colorectal Cancer
Table 2
Change of the RAS gene expression in various cancers.
| Cancer type | RAS gene | RAS protein | Change | Citation |
| Invasive duct cell breast cancer | MMP | Neprilysin | Downregulated | Stephen et al. [113] |
| CRC liver metastases | AGTR1 | AT1R | Upregulated | Neo et al. [15], Zhou et al. [27] | AGTR2 | AT2R | Upregulated | Neo et al. [15] | AGT | Angiotensinogen | No change | Neo et al. [15] | ACE | Angiotensin-converting enzyme | Upregulated | Neo et al. [15] | MAS1 | Mas receptor | Upregulated | Neo et al. [15] |
| CRC | AGTR1 | AT1R | Upregulated, protumoral, and dose dependent on Ang II concentration | Zhou et al. [27] | AGTR2 | AT2R | Biphasic, Ang II dose dependent (, ) | Zhou et al. [27] | AGTR2 | AT2R | Protumor at low (Ang II), antitumoral effects at high (Ang II) | Zhou et al. [27] |
| Breast cancer | AGTR2 | AT2R | Upregulated | Zhou et al. [27] |
| Pancreatic cancer | AGTR2 via ATII | AT2R via ATII | Upregulated | Zhou et al. [27] |
| Chemically induced lung cancer | AGTR2 | AT2R | Upregulated | Zhou et al. [27] |
| CRC, lymph node metastases | ACE | Angiotensin-converting enzyme | Allele dependent | Zheng et al. [16] |
|
|